# Eurofins Advantar Laboratories, Inc – FDA 483, Jun 30, 2026

Source: https://www.keypedia.com/records/483/eurofins-advantar-laboratories-inc/f98de7ac-2761-4994-b643-2d70f0c2fe26

> FDA 483 for Eurofins Advantar Laboratories, Inc on June 30, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eurofins Advantar Laboratories, Inc
- Inspection Date: 2026-06-30
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Eurofins Advantar Laboratories, LLC in San Diego, CA, an API manufacturer and contract testing lab, was cited for failing to follow its written procedures for Annual Product Quality Reviews (APQR). The firm did not establish APQR schedules or finalize reviews for API drug substances in a timely manner as required by its own standard operating procedure. This indicates a lapse in adherence to established quality control processes.

## Related Officers

- [Public Affairs Specialist](https://www.keypedia.com/people/joey-v-quitania/faae874f-94ea-4b63-89d1-649e60726f6f)
- [Alexandra A. Cole](https://www.keypedia.com/people/alexandra-a-cole/6a4ef7be-0d98-4c3c-90a2-ff629ccaf358)

Company: https://www.keypedia.com/companies/eurofins-advantar-laboratories-inc/fe88e38f-0ce0-4e6e-a1bb-ed73634ac024

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6